Detection Of Gene Fusions As Drivers For Targeted Therapies Using Rna Based Comprehensive Genomic Profiling (cgp)
Presented by Illumina
Description:
Genomic alterations known as gene fusions often drive cancer and can be important to detect across many different tumor types. Today, targeted therapies exist for a growing number of gene fusions and have proven to be effective and safe options for patients. However, variation in testing technologies can result in significant differences in the likelihood of fusion identification. In this session we will review the clinical actionability of known and novel driver fusions across tumor types and discuss the role of a CGP approach utilizing both DNA and RNA sequencing to accurately identify all targetable gene fusions.
Speaker: Erica Schnettler
